ArticleCancer control : journal of the Moffitt Cancer Center

Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With

Michael J Fusco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.